Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00511901 · ClinicalTrials.gov registry record · Phase 4
Prevalence and Treatment of Anemia in Rehabilitation Patients
A Phase 4 study, sponsored by University of Medicine and Dentistry of New Jersey.
- Terminated
- Registry status
- Phase 4
- Development phase
- 22
- Enrollment target
NCT00511901 is a Phase 4 study that was terminated before completion, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 22 participants.
The verdict
NCT00511901, a Phase 4 study, was terminated before completion, sponsored by University of Medicine and Dentistry of New Jersey.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 22 participants
- Enrollment target
Study Summary
Patients who are admitted to subacute rehabilitation facilities following hospitalization are frequently anemic. The purpose of this study is to see if anemic patients treated with epoetin alfa will have higher hemoglobin levels and better functional recovery at 3, 8, and 12 weeks after study entry compared to patients who do not receive epoetin alfa.
Interventions
- DRUG placebo
- DRUG epoetin alpha
- DRUG Niferex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2005-11 |
| Est. Completion | 2008-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00511901
The ClinicalTrials.gov registry entry for NCT00511901 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which placebo is the first listed.
NCT00511901 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00511901 about?
NCT00511901 is a clinical study titled "Prevalence and Treatment of Anemia in Rehabilitation Patients". Patients who are admitted to subacute rehabilitation facilities following hospitalization are frequently anemic. The purpose of this study is to see if anemic patients treated with epoetin alfa will have higher hemoglobin levels and better functional recovery at 3, 8, and 12 weeks after study entry ...
What is the current status of trial NCT00511901?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 22 participants. The study started on 2005-11. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00511901?
The interventions under investigation include: placebo (DRUG), epoetin alpha (DRUG), Niferex (DRUG).
Who is sponsoring clinical trial NCT00511901?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.